Language selection

Government of Canada

Search

Food and Drug Regulations

Version of section C.10.008 from 2026-06-17 to 2026-06-17:

  •  (1) Subject to subsection (3) and sections C.10.007.3, C.10.009, C.10.010 and C.10.010.2, a sale of a designated drug is exempt from the following provisions:

    • (a) sections A.01.014 to A.01.017 and A.01.051; and

    • (b) the provisions of Part C other than

      • (i) sections C.01.016, C.01.017, C.01.019 to C.01.020.1 and C.01.040.3 to C.01.051.1,

      • (ii) the provisions of Divisions 1A and 2, and

      • (iii) sections C.10.007.1 to C.10.013.

  • (2) For greater certainty, for the purposes of section C.01.016, the manufacturer of a designated drug is required to comply only with the requirements set out in sections C.01.017 and C.01.019 in respect of the drug.

  • (3) Subsections (1) and (2) cease to apply in respect of the sale of a designated drug on its expiration date.

  • SOR/2021-199, s. 5
  • SOR/2026-96, s. 19

Page Details

Date modified: